The countdown is running. Pharmaceutical companies in Germany are now implementing the EFPIA (European Federation of Pharmaceutical Industries and Association’s) voluntary code on disclosure of transfer of value. The disclosure code is an answer to the general trend towards greater transparency that has swept across public and corporate life. Role model for the code is the US Sunshine Act.

In January companies have started the collection of all information on payments to individual physicians and are going to publish the data from 2016 onwards. More information on implementation of Disclosure Code can be found at www.pharma-transparenz.de.

Companies are now working on implementing systems and cross-national processes to collect the data completely without any duplication. This is a complex process with the challenge of ensuring the disclosure of the accurate data, since thousands of transactions have to be monitored and consolidated, also on multinational level.

Our Healthcare Shapers member Angela Schremmer has developed a software to support companies in implementing the Disclosure Code. See more on her video.